Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi, M.D., as Vice President, Medical
Dr. Galamidi joins Enlivex after 10 years at Gamida Cell Ltd., where she most recently…
News
Noema Pharma announces first patient dosed in Phase 2b LibraTN study of mGluR5 inhibitor NOE-101 in trigeminal neuralgia
Study evaluating the efficacy of NOE-101 for management of pain associated with trigeminal neuralgia BASEL,…
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address…
GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia
MELBOURNE, Australia, Feb. 22, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
– Collaboration includes rights to develop and commercialize ARCALYST® and mavrilimumab in the Asia Pacific…
Statera Biopharma Announces Preliminary Revenue and Financial Results of Fiscal Year ‘21
FORT COLLINS, Colo., Feb. 22, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum
PHILADELPHIA, Feb. 22, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq:…
Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
OTO-313 Phase 2 trial is fully enrolled ahead of schedule Top-line results for all timepoints…
Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIVO
National Cancer Institute Sponsored Phase 1/1b clinical study to test combination of epigenetic and immune-oncology…
Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Oral presentation on neurotrophic and procognitive properties of the active metabolite of fosgonimeton in preclinical…
Verizon, Bloomberg Media, Zixi & AWS test how 5G & mobile edge computing can transform broadcast & content delivery
What you need to know: Verizon, Bloomberg Media, Zixi and AWS are exploring how 5G…
Nozomi Networks Featured on CRN’s 2022 Security 100
SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) — Nozomi Networks, the leader in OT and…
Qeepsake Aims To Help Families Capture and Cherish More Memories With Video Capabilities Launch
Qeepsake’s newest feature, Qeepsake Video is available now for Premium Members to start documenting moments…
Intapp Announces Strategic Partnership with Microsoft to Accelerate Cloud Adoption in Professional and Financial Services Industry
Intapp’s Industry Cloud Delivered Via Microsoft Azure Will Accelerate Digital Transformation for Private Capital, Investment…
Buchanan Technologies Recognized on CRN’s 2022 MSP 500 List
GRAPEVINE, Texas, Feb. 22, 2022 (GLOBE NEWSWIRE) — Buchanan Technologies, a leading IT managed services…
CarGurus™ Instant Max Cash Offer Now Available in California
Platform’s powerful punch delivers convenience, competitive offers for consumers and fresh vehicle sourcing supply for…
John Snow Labs Achieves CarbonNeutral® Company Status, Offsetting its Entire Carbon Footprint for the Company’s Full Operating History
Working with Third-Party Climate Action Veteran Natural Capital Partners, John Snow Labs Minimizes the Environmental…
Onit Continues Accelerated Growth, Reaching 2021 Milestones While Focused on Opportunities for Expansion in 2022
Momentum Highlighted by Three Acquisitions, Extensive Product Innovation and More Than 2,800 Corporate Legal Department Customers…
Aptean Expands Food and Beverage ERP Partner Program in North America
New program helps create food and beverage opportunities for select partners Alliance Partner Program Header…